What type of study is this?

This is a Pre-Registered Trial study.

The feasibility of risk-stratified screening as routine practice in the NHS Breast Screening Programme in England: the PROCAS2 research programme

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals risk-stratified screening improves cost-effectiveness in breast cancer prevention, suggesting future implementation is viable.

Feasibility of risk-stratified screening was demonstrated, indicating it could enhance breast cancer prevention efforts.
The incremental cost-effectiveness ratio of using risk-based screening was found to be £10,500 per quality-adjusted life-year.
Observational study across seven screening sites assessed the integration of BC-Predict into routine practice.
Future efforts may necessitate overcoming barriers initiated by the COVID-19 pandemic to enhance uptake of preventive measures.

French et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis reveals risk-stratified screening improves cost-effectiveness in breast cancer prevention, suggesting future implementation is viable.